
3D Bioprinting Cancer Models: Mimicking the Chaotic Drift of Metastasis
A new review explores how patient-specific bioprinting and organ-on-chip technologies are replacing static lab tests, offering a dynamic way to predict how tumours spread and resist treatment.
By Di Carlo



